- Home
- EHTH vs EPRX Comparison
EHTH vs EPRX Comparison
Compare EHTH & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- EPRX
- Stock Information
- Founded
- EHTH 1997
- EPRX 2011
- Country
- EHTH United States
- EPRX Canada
- Employees
- EHTH N/A
- EPRX N/A
- Industry
- EHTH Specialty Insurers
- EPRX
- Sector
- EHTH Finance
- EPRX
- Exchange
- EHTH Nasdaq
- EPRX NYSE
- Market Cap
- EHTH 133.4M
- EPRX 137.7M
- IPO Year
- EHTH 2006
- EPRX N/A
- Fundamental
- Price
- EHTH $4.20
- EPRX $4.31
- Analyst Decision
- EHTH Hold
- EPRX Strong Buy
- Analyst Count
- EHTH 5
- EPRX 1
- Target Price
- EHTH $7.60
- EPRX $9.00
- AVG Volume (30 Days)
- EHTH 235.5K
- EPRX 14.5K
- Earning Date
- EHTH 08-06-2025
- EPRX 08-07-2025
- Dividend Yield
- EHTH N/A
- EPRX N/A
- EPS Growth
- EHTH N/A
- EPRX N/A
- EPS
- EHTH N/A
- EPRX N/A
- Revenue
- EHTH $552,565,000.00
- EPRX N/A
- Revenue This Year
- EHTH $1.84
- EPRX N/A
- Revenue Next Year
- EHTH $6.72
- EPRX N/A
- P/E Ratio
- EHTH N/A
- EPRX N/A
- Revenue Growth
- EHTH 17.04
- EPRX N/A
- 52 Week Low
- EHTH $3.58
- EPRX $2.20
- 52 Week High
- EHTH $11.36
- EPRX $4.49
- Technical
- Relative Strength Index (RSI)
- EHTH 44.74
- EPRX N/A
- Support Level
- EHTH $3.85
- EPRX N/A
- Resistance Level
- EHTH $4.24
- EPRX N/A
- Average True Range (ATR)
- EHTH 0.23
- EPRX 0.00
- MACD
- EHTH 0.06
- EPRX 0.00
- Stochastic Oscillator
- EHTH 56.45
- EPRX 0.00
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.